AMENDMENT NO. 1 TO TRANSACTION BONUS AGREEMENTTransaction Bonus Agreement • April 26th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 26th, 2013 Company Industry JurisdictionThis AMENDMENT NO. 1 TO TRANSACTION BONUS AGREEMENT (this “Amendment”) is entered into as of April 12, 2013 by and between ANIP Acquisition Company, a Delaware corporation (the “Company”), and James Marken (the “Executive”).
AMENDMENT NO. 2 TO TRANSACTION BONUS AGREEMENTTransaction Bonus Agreement • April 26th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 26th, 2013 Company Industry JurisdictionThis AMENDMENT NO. 2 TO TRANSACTION BONUS AGREEMENT (this “Amendment”) is entered into as of April 12, 2013 by and between ANIP Acquisition Company, a Delaware corporation (the “Company”), and Charlotte Arnold (the “Executive”).
AMENDMENT NO. 1 TO TRANSACTION BONUS AGREEMENTTransaction Bonus Agreement • April 26th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 26th, 2013 Company Industry JurisdictionThis AMENDMENT NO. 1 TO TRANSACTION BONUS AGREEMENT (this “Amendment”) is entered into as of April 12, 2013 by and between ANIP Acquisition Company, a Delaware corporation (the “Company”), and Robert Jamnick (the “Executive”).